Synthetic analogues of bovine bactenecin dodecapeptide reduce herpes simplex virus type 2 infectivity in mice

Håvard Jenssen, Andrey Shestakov, Robert E. W Hancock, Inger Nordström, Kristina Eriksson

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

    Resumé

    We have evaluated the potential of four synthetic peptides (denoted HH-2, 1002, 1006, 1018) with a distant relationship to the host defense peptide bovine bactenecin dodecapeptide for their ability to prevent genital infections with herpes simplex virus type 2 (HSV-2) in mice. All four peptides showed antiviral properties in vitro and reduced HSV-2 infection of Vero cells in a dose-dependent manner. Detailed analysis showed that the peptides were able to interfere with both viral attachment and entry, but not with replication post-entry, and were effective antivirals also when HSV-2 was introduced in human semen. Two of the peptides proved especially effective in reducing HSV-2 infection also in vivo. When admixed with virus prior to inoculation, both HH-2 and 1018 reduced viral replication and disease development in a genital model of HSV-2 infection in mice, and also when using very high infectious doses of HSV-2. These data show that peptides HH-2 and 1018 have antiviral properties and can be used to prevent genital herpes infection in mice. (C) 2013 Elsevier B.V. All rights reserved.
    OriginalsprogEngelsk
    TidsskriftAntiviral Research
    Vol/bind100
    Udgave nummer2
    Sider (fra-til)455-459
    ISSN0166-3542
    DOI
    StatusUdgivet - 2013

    Emneord

    • HSV-2
    • antimicrobial peptides
    • bovine bactenecin
    • syntethic analogues
    • genital herpes

    Citer dette

    Jenssen, Håvard ; Shestakov, Andrey ; Hancock, Robert E. W ; Nordström, Inger ; Eriksson, Kristina. / Synthetic analogues of bovine bactenecin dodecapeptide reduce herpes simplex virus type 2 infectivity in mice. I: Antiviral Research. 2013 ; Bind 100, Nr. 2. s. 455-459.
    @article{29ba4a71d67b4e42b869406566bde164,
    title = "Synthetic analogues of bovine bactenecin dodecapeptide reduce herpes simplex virus type 2 infectivity in mice",
    abstract = "We have evaluated the potential of four synthetic peptides (denoted HH-2, 1002, 1006, 1018) with a distant relationship to the host defense peptide bovine bactenecin dodecapeptide for their ability to prevent genital infections with herpes simplex virus type 2 (HSV-2) in mice. All four peptides showed antiviral properties in vitro and reduced HSV-2 infection of Vero cells in a dose-dependent manner. Detailed analysis showed that the peptides were able to interfere with both viral attachment and entry, but not with replication post-entry, and were effective antivirals also when HSV-2 was introduced in human semen. Two of the peptides proved especially effective in reducing HSV-2 infection also in vivo. When admixed with virus prior to inoculation, both HH-2 and 1018 reduced viral replication and disease development in a genital model of HSV-2 infection in mice, and also when using very high infectious doses of HSV-2. These data show that peptides HH-2 and 1018 have antiviral properties and can be used to prevent genital herpes infection in mice. (C) 2013 Elsevier B.V. All rights reserved.",
    keywords = "HSV-2, antimicrobial peptides, bovine bactenecin, syntethic analogues, genital herpes, HSV-2, antimicrobial peptides, bovine bactenecin, syntethic analogues, genital herpes",
    author = "H{\aa}vard Jenssen and Andrey Shestakov and Hancock, {Robert E. W} and Inger Nordstr{\"o}m and Kristina Eriksson",
    year = "2013",
    doi = "10.1016/j.antiviral.2013.08.019",
    language = "English",
    volume = "100",
    pages = "455--459",
    journal = "Antiviral Research",
    issn = "0166-3542",
    publisher = "Elsevier BV",
    number = "2",

    }

    Synthetic analogues of bovine bactenecin dodecapeptide reduce herpes simplex virus type 2 infectivity in mice. / Jenssen, Håvard; Shestakov, Andrey; Hancock, Robert E. W; Nordström, Inger; Eriksson, Kristina.

    I: Antiviral Research, Bind 100, Nr. 2, 2013, s. 455-459.

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

    TY - JOUR

    T1 - Synthetic analogues of bovine bactenecin dodecapeptide reduce herpes simplex virus type 2 infectivity in mice

    AU - Jenssen, Håvard

    AU - Shestakov, Andrey

    AU - Hancock, Robert E. W

    AU - Nordström, Inger

    AU - Eriksson, Kristina

    PY - 2013

    Y1 - 2013

    N2 - We have evaluated the potential of four synthetic peptides (denoted HH-2, 1002, 1006, 1018) with a distant relationship to the host defense peptide bovine bactenecin dodecapeptide for their ability to prevent genital infections with herpes simplex virus type 2 (HSV-2) in mice. All four peptides showed antiviral properties in vitro and reduced HSV-2 infection of Vero cells in a dose-dependent manner. Detailed analysis showed that the peptides were able to interfere with both viral attachment and entry, but not with replication post-entry, and were effective antivirals also when HSV-2 was introduced in human semen. Two of the peptides proved especially effective in reducing HSV-2 infection also in vivo. When admixed with virus prior to inoculation, both HH-2 and 1018 reduced viral replication and disease development in a genital model of HSV-2 infection in mice, and also when using very high infectious doses of HSV-2. These data show that peptides HH-2 and 1018 have antiviral properties and can be used to prevent genital herpes infection in mice. (C) 2013 Elsevier B.V. All rights reserved.

    AB - We have evaluated the potential of four synthetic peptides (denoted HH-2, 1002, 1006, 1018) with a distant relationship to the host defense peptide bovine bactenecin dodecapeptide for their ability to prevent genital infections with herpes simplex virus type 2 (HSV-2) in mice. All four peptides showed antiviral properties in vitro and reduced HSV-2 infection of Vero cells in a dose-dependent manner. Detailed analysis showed that the peptides were able to interfere with both viral attachment and entry, but not with replication post-entry, and were effective antivirals also when HSV-2 was introduced in human semen. Two of the peptides proved especially effective in reducing HSV-2 infection also in vivo. When admixed with virus prior to inoculation, both HH-2 and 1018 reduced viral replication and disease development in a genital model of HSV-2 infection in mice, and also when using very high infectious doses of HSV-2. These data show that peptides HH-2 and 1018 have antiviral properties and can be used to prevent genital herpes infection in mice. (C) 2013 Elsevier B.V. All rights reserved.

    KW - HSV-2

    KW - antimicrobial peptides

    KW - bovine bactenecin

    KW - syntethic analogues

    KW - genital herpes

    KW - HSV-2

    KW - antimicrobial peptides

    KW - bovine bactenecin

    KW - syntethic analogues

    KW - genital herpes

    U2 - 10.1016/j.antiviral.2013.08.019

    DO - 10.1016/j.antiviral.2013.08.019

    M3 - Journal article

    VL - 100

    SP - 455

    EP - 459

    JO - Antiviral Research

    JF - Antiviral Research

    SN - 0166-3542

    IS - 2

    ER -